Literature DB >> 23249752

Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors.

Rasmus O Bak1, Anne Kruse Hollensen, Maria Nascimento Primo, Camilla Darum Sørensen, Jacob Giehm Mikkelsen.   

Abstract

MicroRNAs (miRNAs) are key regulators of gene expression and modulators of diverse biological pathways. Analyses of miRNA function as well as therapeutic managing of miRNAs rely on cellular administration of miRNA inhibitors which may be achieved by the use of viral vehicles. This study explores the miRNA-suppressive capacity of inhibitors expressed intracellularly from lentivirus-derived gene vectors. Superior activity of two decoy-type inhibitors, a "Bulged Sponge" with eight miRNA recognition sites and a hairpin-shaped "Tough Decoy" containing two miRNA recognition sites, is demonstrated in a side-by-side comparison of seven types of miRNA inhibitors transcribed as short RNAs from an RNA Pol III promoter. We find that lentiviral vectors expressing Tough Decoy inhibitors are less vulnerable than Bulged Sponge-encoding vectors to targeting by the cognate miRNA and less prone, therefore, to reductions in transfer efficiency. Importantly, it is demonstrated that Tough Decoy inhibitors retain their miRNA suppression capacity in the context of longer RNA transcripts expressed from an RNA Pol II promoter. Such RNA Pol II-transcribed Tough Decoy inhibitors are new tools in managing of miRNAs and may have potential for temporal and spatial regulation of miRNA activity as well as for therapeutic targeting of miRNAs that are aberrantly expressed in human disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23249752      PMCID: PMC3543086          DOI: 10.1261/rna.034850.112

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  47 in total

1.  RNA interference is mediated by 21- and 22-nucleotide RNAs.

Authors:  S M Elbashir; W Lendeckel; T Tuschl
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

2.  Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro.

Authors:  C H Miao; K Ohashi; G A Patijn; L Meuse; X Ye; A R Thompson; M A Kay
Journal:  Mol Ther       Date:  2000-06       Impact factor: 11.454

3.  Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells.

Authors:  Yan Zeng; Eric J Wagner; Bryan R Cullen
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

4.  CRE recombinase-inducible RNA interference mediated by lentiviral vectors.

Authors:  Gustavo Tiscornia; Vinay Tergaonkar; Francesco Galimi; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-30       Impact factor: 11.205

5.  A detailed model of reverse transcription and tests of crucial aspects.

Authors:  E Gilboa; S W Mitra; S Goff; D Baltimore
Journal:  Cell       Date:  1979-09       Impact factor: 41.582

6.  Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells.

Authors:  W An; A Telesnitsky
Journal:  Virology       Date:  2001-08-01       Impact factor: 3.616

7.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

8.  Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector.

Authors:  Marc van de Wetering; Irma Oving; Vanesa Muncan; Menno Tjon Pon Fong; Helen Brantjes; Dik van Leenen; Frank C P Holstege; Thijn R Brummelkamp; Reuven Agami; Hans Clevers
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

9.  Nuclear export of microRNA precursors.

Authors:  Elsebet Lund; Stephan Güttinger; Angelo Calado; James E Dahlberg; Ulrike Kutay
Journal:  Science       Date:  2003-11-20       Impact factor: 47.728

10.  Sequence-specific inhibition of small RNA function.

Authors:  György Hutvágner; Martin J Simard; Craig C Mello; Phillip D Zamore
Journal:  PLoS Biol       Date:  2004-02-24       Impact factor: 8.029

View more
  37 in total

1.  MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma.

Authors:  Hanne Due; Anna Amanda Schönherz; Laura Ryø; Maria Nascimento Primo; Ditte Starberg Jespersen; Emil Aagaard Thomsen; Anne Stidholt Roug; Min Xiao; Xiaohong Tan; Yuyang Pang; Ken H Young; Martin Bøgsted; Jacob Giehm Mikkelsen; Karen Dybkær
Journal:  Blood Adv       Date:  2019-04-09

Review 2.  Managing microRNAs with vector-encoded decoy-type inhibitors.

Authors:  Rasmus O Bak; Anne Kruse Hollensen; Jacob Giehm Mikkelsen
Journal:  Mol Ther       Date:  2013-06-11       Impact factor: 11.454

3.  Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.

Authors:  Stefan Mockenhaupt; Stefanie Grosse; Daniel Rupp; Ralf Bartenschlager; Dirk Grimm
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

4.  MiR-124 synergism with ELAVL3 enhances target gene expression to promote neuronal maturity.

Authors:  Ya-Lin Lu; Yangjian Liu; Matthew J McCoy; Andrew S Yoo
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

Review 5.  Adeno-associated virus-mediated microRNA delivery and therapeutics.

Authors:  Jun Xie; Daniel Robert Burt; Guangping Gao
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

6.  Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors.

Authors:  Anne Kruse Hollensen; Rasmus O Bak; Didde Haslund; Jacob Giehm Mikkelsen
Journal:  RNA Biol       Date:  2013-01-16       Impact factor: 4.652

Review 7.  Recombinant AAV as a platform for translating the therapeutic potential of RNA interference.

Authors:  Florie Borel; Mark A Kay; Christian Mueller
Journal:  Mol Ther       Date:  2013-12-19       Impact factor: 11.454

8.  Neuronal microRNAs modulate TREK two-pore domain K+ channel expression and current density.

Authors:  Maria Paschou; Larisa Maier; Panagiota Papazafiri; Tudor Selescu; Skarlatos G Dedos; Alexandru Babes; Epaminondas Doxakis
Journal:  RNA Biol       Date:  2020-02-10       Impact factor: 4.652

Review 9.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 10.  Small RNAs: a new frontier in mosquito biology.

Authors:  Keira J Lucas; Kevin M Myles; Alexander S Raikhel
Journal:  Trends Parasitol       Date:  2013-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.